Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Ocular Therapeutix
Biotech
Flagship-backed biotechs name new leaders—Chutes & Ladders
Flagship-backed biotechs name new leaders. Rubedo wrangles Allergan vet as new CEO. Zipping toward commercialization, Zentalis taps new leadership.
Darren Incorvaia
,
Zoey Becker
Nov 15, 2024 8:30am
Exscientia fires CEO—Chutes & Ladders
Feb 16, 2024 9:30am
Forte taps new exec amid shareholder dissent—Chutes & Ladders
Jun 10, 2022 9:30am
Ocular's drug-eluting insert for dry eye disease misses endpoint
Oct 22, 2021 11:09am
Ocular's drug insert just misses bull's-eye in glaucoma trial
May 21, 2019 9:53am
FDA again rejects Ocular drug over manufacturing failings
Jul 12, 2017 4:59am
